News

HeartBeam (Nasdaq:BEAT) today announced that a study of its synthesized 12-lead electrocardiogram (ECG) met its clinical ...
The study evaluated the mean difference in ECG intervals and amplitudes between HeartBeam's synthesized 12-lead ECG and simultaneously collected standard 12-lead ECG that are important in assessing ...
"The ability to deliver 12-lead ECG-like data through a credit card-sized device that patients can use whenever and wherever arrhythmia symptoms occur underscores our long-term vision of bringing ...
HeartBeam rolled out an application for its 12-lead ECG synthesis software to the FDA, based on the data from the study.
HeartBeam has announced a partnership with electrocardiogram (ECG)-based diagnostics software company AccurKardia, aimed at ...
This is the offical code repository accompanying our paper on Self-supervised representation learning from 12-lead ECG data. For a detailed description of technical details and experimental results, ...